GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

As India awaits the launch of obesity drug, Mounjaro, the debate on weight loss drugs and body image continues ...

The manufacturer of the weight loss jab Wegovy has been reprimanded for allegedly failing to disclose or accurately report ...

Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...

In the face of abrupt weight loss, one of the most common consequences is hair loss, even after bariatric surgery. Losing ...

RANI READ THE FULL RANI RESEARCH REPORT On February 5 th , Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) shared its preclinical readout from the RT-116 study demonstrating successful oral delivery of ...

The increase in weight loss with the higher dose was impressive ... Wegovy and two other semaglutide products – Ozempic and Rybelsus for type 2 diabetes – have been included on the list ...

Weight loss that resulted from the drug was probably ... listed on the labels for semaglutide in the form of Ozempic, Rybelsus and Wegovy, Novo Nordisk said in a statement. Data from clinical ...

Pursuing the world's first-ever orally-dosed liraglutide KELOWNA, BC / ACCESS Newswire / February 20, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global ...

A new study published in the journal JAMA Psychiatry found that semaglutide (sold under brand names like Ozempic and Wegovy) ...